Dr. Reddy's Laboratories (RDY) announced that it has launched Clopidogrel Tablets, USP75 mg & 300 mg, a bioequivalent generic version of PLAVIX, in the U.S. market on May 18, 2012. The ANDAs for Clopidogrel Tablets USP,75 mg & 300 mg are approved by the United States Food & Drug Administration, or FDA.
Dr. Reddy's Clopidogrel Tablets USP, 75 mg are available in bottle count sizes of 30, 90 and 500, and Clopidogrel Tablets USP, 300 mg are available in blister packs of 30's count.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.